Pages that link to "Q69485434"

The following pages link to Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results (Q69485434):

Displaying 39 items.

• Haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia (Q26799396) (← links)
• Alternative donor transplant of benign primary hematologic disorders (Q26823398) (← links)
• Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes (Q26863182) (← links)
• Second unrelated donor hematopoietic cell transplantation for primary graft failure (Q33965423) (← links)
• Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen. (Q34180301) (← links)
• Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes (Q34228345) (← links)
• Recent advances in treatment of aplastic anemia (Q34451351) (← links)
• Stem cell transplantation for aplastic anemia (Q34591775) (← links)
• Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens (Q34824419) (← links)
• Mechanisms of alloimmunization and subsequent bone marrow transplantation rejection induced by platelet transfusion in a murine model (Q34976550) (← links)
• The international bone marrow transplant registry (Q34996172) (← links)
• Conditioning with rabbit versus horse ATG dramatically alters clinical outcomes in identical twins with severe aplastic anemia transplanted with the same allogeneic donor (Q35805248) (← links)
• Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease (Q35811966) (← links)
• Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens (Q35828656) (← links)
• Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. (Q35925091) (← links)
• HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival. (Q36120565) (← links)
• Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders (Q36305355) (← links)
• Favorable preliminary results using TLI/ATG-based immunomodulatory conditioning for matched unrelated donor allogeneic hematopoietic stem cell transplantation in pediatric severe aplastic anemia. (Q36514033) (← links)
• Total lymphoid irradiation based conditioning for hematopoietic stem cell transplantation in severe aplastic anemia (Q36537051) (← links)
• A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation (Q36941032) (← links)
• Graft failure after allogeneic hematopoietic cell transplantation (Q37045988) (← links)
• Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia (Q37216096) (← links)
• Transfusion of minor histocompatibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice. (Q37328417) (← links)
• Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model (Q37351058) (← links)
• Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant (Q37597265) (← links)
• Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases (Q37600436) (← links)
• Principles and overview of allogeneic hematopoietic stem cell transplantation. (Q37603180) (← links)
• Selective resistance of CD44hi T cells to p53-dependent cell death results in persistence of immunologic memory after total body irradiation (Q38625892) (← links)
• Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis (Q38879870) (← links)
• Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI. (Q40014997) (← links)
• Hepatitis associated with aplastic anemia: do CD8(+) kupffer cells have a role in the pathogenesis? (Q44058199) (← links)
• Allogeneic transplantation using CD34+ selected peripheral blood progenitor cells combined with non-mobilized donor T cells for refractory severe aplastic anaemia (Q48840457) (← links)
• Allogeneic Matched Related Donor Bone Marrow Transplantation for Pediatric Patients With Severe Aplastic Anemia Using "Low-dose" Cyclophosphamide, ATG Plus Fludarabine (Q50063111) (← links)
• Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia (Q50239379) (← links)
• Refinement of treatment strategies in ex vivo T-cell-depleted haploidentical SCT for pediatric patients. (Q53255406) (← links)
• Successful outcomes of second hematopoietic stem cell transplantation with total nodal irradiation and ATG conditioning for graft failure in adult patients with severe aplastic anemia (Q57134829) (← links)
• Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: Preliminary results (Q72009312) (← links)
• Hematopoietic stem cell transplantation for severe aplastic anemia--experience of an institute in Taiwan (Q79126672) (← links)
• Aplastic Anemia Preconditioned with Fludarabine, Cyclophosphamide, and Anti-Thymocyte Globulin (Q92509156) (← links)